INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 126 filers reported holding INOVIO PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.68 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $12,755,000 | -25.3% | 1,837,861 | +0.3% | 0.00% | -33.3% |
| Q3 2016 | $17,086,000 | +1.9% | 1,833,262 | +1.0% | 0.00% | 0.0% |
| Q2 2016 | $16,774,000 | +3.2% | 1,815,319 | -2.8% | 0.00% | 0.0% |
| Q1 2016 | $16,261,000 | +29.5% | 1,866,926 | -0.1% | 0.00% | +50.0% |
| Q4 2015 | $12,557,000 | +33.3% | 1,868,566 | +14.6% | 0.00% | 0.0% |
| Q3 2015 | $9,422,000 | -24.0% | 1,630,088 | +7.3% | 0.00% | 0.0% |
| Q2 2015 | $12,397,000 | +20.7% | 1,519,243 | +20.7% | 0.00% | 0.0% |
| Q1 2015 | $10,272,000 | +21.3% | 1,258,879 | +36.5% | 0.00% | +100.0% |
| Q4 2014 | $8,467,000 | +30.2% | 922,310 | +39.6% | 0.00% | 0.0% |
| Q3 2014 | $6,505,000 | -16.1% | 660,456 | -7.9% | 0.00% | 0.0% |
| Q2 2014 | $7,750,000 | – | 716,965 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 581,100 | $2,324,000 | 2.21% |
| Round Table Services, LLC | 339,391 | $1,358,000 | 0.52% |
| ARK Investment Management | 1,885,641 | $7,543,000 | 0.31% |
| WASATCH ADVISORS LP | 5,337,930 | $21,352,000 | 0.28% |
| Cedar Brook Financial Partners, LLC | 41,500 | $166,000 | 0.10% |
| Unified Trust Company, N.A. | 13,716 | $54,000 | 0.05% |
| Virtus ETF Advisers LLC | 60,398 | $242,000 | 0.04% |
| OXFORD ASSET MANAGEMENT LLP | 394,703 | $1,579,000 | 0.04% |
| FOX RUN MANAGEMENT, L.L.C. | 14,465 | $58,000 | 0.03% |
| BREWIN DOLPHIN LTD | 59,123 | $236,492 | 0.03% |